~~<i id='12E9DE7B9F'><strike id='12E9DE7B9F'><tt id='12E9DE7B9F'><pre id='12E9DE7B9F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：Wikipedia 2025-10-01 20:12:18 - browse：85332

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

explore

hotspot

explore

focus

hotspot

entertainment

1:30Twosixty-five-footraceyachtshadacloseencounterwithorcawhalesastheyapproachedtheStraitofGibraltar

WSS

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

California’s proposed $25 per hour health care minimum wage

How the political right came to back psychedelics to treat trauma

New weight loss drugs work. But how can they best be used?

Charles Manson follower Leslie Van Houten released from prison after 53 years

AdventHealth escalates lawsuit against insurance vendor Multiplan

focus

knowledge

explore

In Memoriam: Notable people who died in 2023

Oak trusses raised to roof of fire

Sports medicine is finally prioritizing gender equality

Leqembi, other new Alzheimer’s drugs require better biomarkers

George Santos makes 1st court appearance after pleading not guilty to 13 counts

U.K. sequencing study surfaces new findings about tumor DNA

Activists slam private health insurers over coverage restrictions

New research casts further doubt on a common procedure used with IVF

At least 13 dead in Texas as scorching temps continue

U.K. sequencing study surfaces new findings about tumor DNA

hotspot

Iowa House, Senate pass 6

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

J&J to buy cancer drug developer Ambrx Biopharma

New research casts further doubt on a common procedure used with IVF

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Biden launches a new push to limit health care costs

explore

focus

hotspot

entertainment